These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12239744)

  • 1. A multiple source methodology for the surveillance of fetal alcohol syndrome--The Fetal Alcohol Syndrome Surveillance Network (FASSNet).
    Hymbaugh K; Miller LA; Druschel CM; Podvin DW; Meaney FJ; Boyle CA;
    Teratology; 2002; 66 Suppl 1():S41-9. PubMed ID: 12239744
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal alcohol syndrome--Alaska, Arizona, Colorado, and New York, 1995-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 May; 51(20):433-5. PubMed ID: 12056499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating prevalence of fetal alcohol syndrome (FAS): effectiveness of a passive birth defects registry system.
    Fox DJ; Druschel CM
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):604-8. PubMed ID: 14703781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in estimating the prevalence of fetal alcohol syndrome: examination of 2 counties in New York State.
    Druschel CM; Fox DJ
    Pediatrics; 2007 Feb; 119(2):e384-90. PubMed ID: 17272600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking multiple data sources in fetal alcohol syndrome surveillance--Alaska.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(16):312-4. PubMed ID: 8474426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of fetal alcohol syndrome surveillance network and birth defects surveillance methodology in determining prevalence rates of fetal alcohol syndrome.
    Meaney FJ; Miller LA;
    Birth Defects Res A Clin Mol Teratol; 2003 Sep; 67(9):819-22. PubMed ID: 14703793
    [No Abstract]   [Full Text] [Related]  

  • 7. From the Centers for Disease Control and Prevention. Fetal alcohol syndrome--Alaska, Arizona, Colorado, and New York, 1995-1997.
    JAMA; 2002 Jul; 288(1):38-40. PubMed ID: 12099269
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinical intervention for children exposed to alcohol in utero.
    Li C; Pearson K
    Alaska Med; 1996; 38(4):124-31, 147. PubMed ID: 9124639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for fetal alcohol syndrome using multiple sources -- Atlanta, Georgia, 1981-1989.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(47):1118-20. PubMed ID: 9393658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetal alcohol syndrome prevention in Washington State: evidence of success.
    Astley SJ
    Paediatr Perinat Epidemiol; 2004 Sep; 18(5):344-51. PubMed ID: 15367321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alaska Fetal Alcohol Syndrome Prevention Project.
    Jones L; Nakamura P
    Alaska Med; 1993; 35(2):179. PubMed ID: 8238775
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the 4-digit diagnostic code and the Hoyme diagnostic guidelines for fetal alcohol spectrum disorders.
    Astley SJ
    Pediatrics; 2006 Oct; 118(4):1532-45. PubMed ID: 17015544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the fetal alcohol syndrome facial photographic screening tool in a foster care population.
    Astley SJ; Stachowiak J; Clarren SK; Clausen C
    J Pediatr; 2002 Nov; 141(5):712-7. PubMed ID: 12410204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interface between dysmorphology and epidemiology in the "diagnosis" and surveillance for fetal alcohol effects.
    Khoury MJ; Boyle C; DeCoufle P; Floyd L; Hymbaughm K
    Pediatrics; 1996 Aug; 98(2 Pt 1):315-6. PubMed ID: 8692645
    [No Abstract]   [Full Text] [Related]  

  • 15. Fetal alcohol syndrome among children aged 7-9 years - Arizona, Colorado, and New York, 2010.
    Fox DJ; Pettygrove S; Cunniff C; O'Leary LA; Gilboa SM; Bertrand J; Druschel CM; Breen A; Robinson L; Ortiz L; Frías JL; Ruttenber M; Klumb D; Meaney FJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(3):54-7. PubMed ID: 25632951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wisconsin Fetal Alcohol Syndrome Screening Project.
    Weiss M; Cronk CE; Mahkorn S; Glysch R; Zirbel S
    WMJ; 2004; 103(5):53-60. PubMed ID: 15553566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fetal alcohol syndrome: prevalence in 4 special education schools in Chile].
    Mena M; Nazal R; Albornoz C; Pettinelli H; Velásquez P; Soza G
    Rev Med Chil; 1988 Dec; 116(12):1252-6. PubMed ID: 3267910
    [No Abstract]   [Full Text] [Related]  

  • 18. Methods for surveillance of fetal alcohol syndrome: The Fetal Alcohol Syndrome Surveillance Network II (FASSNetII) - Arizona, Colorado, New York, 2009 - 2014.
    O'Leary LA; Ortiz L; Montgomery A; Fox DJ; Cunniff C; Ruttenber M; Breen A; Pettygrove S; Klumb D; Druschel C; Frías JL; Robinson LK; Bertrand J; Ferrara K; Kelly M; Gilboa SM; Meaney FJ;
    Birth Defects Res A Clin Mol Teratol; 2015 Mar; 103(3):196-202. PubMed ID: 25761572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies.
    May PA; Gossage JP; Kalberg WO; Robinson LK; Buckley D; Manning M; Hoyme HE
    Dev Disabil Res Rev; 2009; 15(3):176-92. PubMed ID: 19731384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology.
    Miller LA; Romitti PA; Cunniff C; Druschel C; Mathews KD; Meaney FJ; Matthews D; Kantamneni J; Feng ZF; Zemblidge N; Miller TM; Andrews J; Fox D; Ciafaloni E; Pandya S; Montgomery A; Kenneson A
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):793-7. PubMed ID: 17036307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.